Drugs / Therapeutic Estradiol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06179303 Background | Jul 2024 → Mar 2027 expected | female breast carcinoma, hormone receptor-positive breast cancer | University of Washington | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Therapeutic Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06179303 ↗ |
| Route | Oral | “Given PO” NCT06179303 ↗ |